๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Pharmacokinetics and pharmacodynamics of doxorubicin in patients with small cell lung cancer

Book ID
122884871
Publisher
Elsevier Science
Year
1994
Tongue
English
Weight
146 KB
Volume
10
Category
Article
ISSN
0169-5002

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

The effects of cyclosporine on the pharm
The effects of cyclosporine on the pharmacokinetics of doxorubicin in patients with small cell lung cancer
โœ Daniel A. Rushing; Susan R. Raber; Keith A. Rodvold; Stephen C. Piscitelli; Gary ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 723 KB

Background. The authors compared the pharmacokinetics of doxorubicin when administered with and without concomitant high dose cyclosporine for multidrug resistant (MDR) tumor modulation in small cell lung cancer. Methods. Eight patients with small cell lung cancer served as their own controls and w

Chromatographic analysis and pharmacokin
Chromatographic analysis and pharmacokinetics of liposome-encapsulated doxorubicin in non-small-cell lung cancer patients
โœ Leanne Embree; Karen A. Gelmon; Andreas Lohr; Lawrence D. Mayer; Andrew J. Coldm ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 1024 KB

A sensitive and specific quantitative assay for total doxorubicin concentrations in plasma containing liposome-encapsulated doxorubicin hydrochloride (TLC D-99) was developed, with solvent extraction and reversed-phase high-performance liquid chromatography (HPLC). Separation of doxorubicin from its